FIELD: medicine. SUBSTANCE: method involves sorption of factor IX on sorbent DEAE-Toyopearl from cryosupernatant of donor plasma, ion-exchanger washing, elution of factor IX, dialysis and concentration of the end product on the semipermeable hole fibers. EFFECT: improved quality of product, increased specific activity (units per mg protein), increased yield of product. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING HUMAN C-1 ESTERASE INHIBITOR AMD PRODUCT FOR USING IN MEDICINE | 2004 |
|
RU2256464C1 |
| METHOD FOR MAKING HUMAN COAGULATION FACTOR IX CONCENTRATE | 2007 |
|
RU2353386C1 |
| METHOD FOR PRODUCING PURIFIED ACTIVATED BLOOD COAGULATION X-FACTOR | 2002 |
|
RU2221578C1 |
| METHOD FOR PRODUCING CONCENTRATED FACTOR VIII OF HUMAN BLOOD PLASMA | 2010 |
|
RU2445974C2 |
| METHOD FOR OBTAINING A LIOPHILIZED PREPARATION OF AN ACTIVATED PROTROMBIN COMPLEX HAVING VIII-SHUNTING ACTIVITY FACTOR | 2017 |
|
RU2648517C1 |
| METHOD OF OBTAINING VIRUS-SAFE COMPLETE PROTHROMBIN COMPLEX | 2014 |
|
RU2559576C1 |
| METHOD OF PRODUCING THROMBIN CONCENTRATE | 2014 |
|
RU2583931C2 |
| METHOD OF PURIFICATION AND STORAGE OF, AQUEOUS SOLUTION OF PURIFIED FACTOR IX, COMPOSITION CONTAINING FACTOR IX, AND METHOD OF TREATMENT | 1992 |
|
RU2142806C1 |
| METHOD OF PRODUCING PROTEINS OF 3200-3400 MOLECULAR WEIGHT, SUPPRESSING BLOOD COAGULATION | 0 |
|
SU1512473A3 |
| METHOD OF ANTITROMBIN III MEDICATION PREPARATION OF HUMAN PLASMA | 2008 |
|
RU2357742C1 |
